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Full-length genomes of the feline foamy virus (FFV or FeFV) isolate FUV were constructed. DNA clone pFeFV-7 stably
directed the expression of infectious FFV progeny virus indistinguishable from wild-type, uncloned FFV isolate FUV. The env
and bel 1 genes of pFeFV-7 were substituted for by corresponding sequences of the FFV serotype 951 since previous studies
implicated a defined part of FFV Env protein as responsible for serotype-specific differences in serum neutralization (I. G.
Winkler, R. M. Flu¨gel, M. Lo¨chelt, and R. L. P. Flower, 1998. Virology 247: 144–151). Recombinant virus derived from chimeric
plasmid pFeFV-7/951 containing the hybrid env gene and the parental clone pFeFV-7 were used for neutralization studies. By
means of a rapid titration assay for FFV infectivity, we show that progeny virus derived from plasmid pFeFV-7 was neutralized
by FUV- but not by 951-specific antisera, whereas pFeFV-7/951-derived chimeric virus was neutralized by 951-specific
antisera only. Both recombinant proviruses will be useful for repeated delivery of foreign genes for therapeutic gene
applications into cats. © 2000 Academic PressINTRODUCTION
Spumaretroviruses or foamy viruses (FV) are consid-
ered as potential vectors for targeted gene delivery due
to their apparent apathogenicity and peculiar aspects in
their mode of replication and gene expression (Mergia
and Luciw, 1991; Lo¨chelt and Flu¨gel, 1995; Rethwilm,
1995; Coffin, 1996; Yu et al., 1996; Linial, 1999). We started
to work on feline foamy virus (FFV) to establish an animal
model for investigating the potential and applicability of
FV-derived vectors for targeted gene delivery and to
study FV replication in its natural host. Administering
FFV-based vectors into cats represents an experimental
system to investigate the versatility of spumaretroviral
vectors, e.g., by interfering with replication and pathoge-
nicity of feline immunodeficiency virus (FIV). Those stud-
ies are of general interest as infection of cats with FIV
results in virtually identical clinical symptoms character-
istic for HIV-induced AIDS in man (Elder et al., 1998). FFV
was repeatedly isolated from and detected in naturally
infected cats that were apparently healthy or suffered
from diverse diseases, and its role as a copathogen for
FIV is still under debate (Riggs et al., 1969; Hackett et al.,
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151970; Flower et al., 1985; Bendecchi et al., 1992; Loh,
1993; Winkler et al., 1999).
Our previous studies showed that FFV is clearly distinct
from the closely related primate FVs, but major aspects of
gene expression and replication are conserved among
known FVs (Bodem et al., 1996, 1998a,b; Winkler et al.,
1997). Although different FV isolates from the same host
species usually differ only slightly in their genetic coding
capacity (Lo¨chelt and Flu¨gel, 1995), two distinct serotypes
of FFV have been characterized (Flower et al., 1985; Helps
and Harbor, 1997; Winkler et al., 1997). Sequencing mem-
bers of each of these FFV serotypes revealed that the major
difference in the coding capacity is confined to the central
and carboxyl-terminal part of the Env SU protein (Helps and
Harbor, 1997; Winkler et al., 1997). This part of FFV Env was
also found to be the major target for neutralizing antibodies
(Winkler et al., 1998).
To extend these studies, we constructed FFV genomes
with serotype-specific differences in Env and Bel 1 (also
designated Tas for transactivator of spumaviruses) and
show that they are not cross-neutralized in a rapid neu-
tralization assay.
RESULTS
Construction of FFV-FAB indicator cells for FFV
titrationTo establish FFV-FAB cells for rapid and sensitive









































































151NEUTRALIZATION-RESISTANT FOAMY VIRUS GENOMESfor the titration of human foamy virus (HFV) on BHK cells
(Yu and Linial, 1993), a plasmid containing part of the FFV
U3 promoter upstream of a nuclear targeted b-gal gene
was established. Transient transfection of pFeFV-U3-b-
al together with an FFV Bel 1 expression plasmid re-
ulted in the strong expression of b-gal, whereas without
el 1 coexpression, no b-gal activity was detectable at
the single-cell level (data not shown). Plasmid pFeFV-U3-
b-gal was transfected together with a plasmid coding for
G418 resistance (Sambrook et al., 1989). G418-resistant
lones were selected by single-cell cloning. One single-
ell clone turned out to stably contain plasmid pFeFV-
3-b-gal and showed b-gal expression only upon FFV
nfection or FFV Bel 1 transfection (data not shown).
FV-FAB cells allow the sensitive detection and titration
f cell-culture-adapted FFV strains FUV and 951 and FFV
solated directly from FFV-infected cats (data not shown).
he titer determined is expressed as (blue) focus forming
nit per milliliter (FFU/ml; Yu and Linial, 1993).
onstruction of infectious FFV-FUV genome pFeFV-7
To construct infectious, full-length FFV DNA clones,
FV DNA was amplified by long-template PCR using
pecific primers and DNA from FFV-FUV-infected CRFK
ells as template as described previously (Winkler et al.,
997). Amplicons were either subcloned or directly in-
erted into already existing FFV DNA clones as de-
cribed under Material and Methods (Winkler et al.,
997). Colinear FFV DNA from nt position 17 to 11,700 in
he pBluescript backbone was subcloned into vector
AT153. Several independent and genetically stable re-
ombinant clones were analyzed after transfection into
FV-permissive CRFK cells; most of them had only a low
evel of infectivity. Because FFV clone 13 showed mod-
rate viral infectivity, it was used to fully restore FFV
nfectivity by substituting FFV DNA sequences from nt
980 to 10,137 by FFV DNA obtained by direct PCR
mplification from FFV-infected CRFK cells. The resulting
FV clone pFeFV-7 was genetically stable in bacteria. To
etermine the infectivity of clone pFeFV-7, DNA was
ransfected into permissive CRFK cells and viral infectiv-
ty was determined by infecting CRFK cell-derived FFV-
AB cells. Cell-free supernatants from CRFK cells har-
ested 3 days after transfection with plasmid pFeFV-7
eproducibly yielded titers of ;105 FFU/ml when assayed
on FFV-FAB cells. After longer incubation, the titer in-
creased gradually to ;107 FFU/ml. Virus derived from
FeFV-7-transfected cells was infectious for CRFK cells,
nduced the formation of syncytia, and maintained a titer
f $107 FFU/ml upon serial passage on CRFK cells
indistinguishable from uncloned, wild-type FFV. Superna-
tants from untreated or pUC18-transfected CRFK cells
did not induce the characteristic nuclear blue staining of
FFV-infected FFV-FAB cells.
Sequencing of pFeFV-7 DNA revealed minor alter-
c
aations of the primary nt sequence and the deduced
amino acid sequence in comparison to the sequence
described previously (Winkler et al., 1997): A5379G, Pol
N815D; T5555C, silent; T6787C, Env F157L; T7086C, si-
lent; A7279G, Env N321D; G8258A, Env R647K; A8750G,
Env D811G; G9067A, Env D917N; C9135T, silent; A9557G,
silent. It is unknown whether these differences reflect the
genetic variability of FFV in cultured cells or are due to
PCR amplification or a combination of both.
Construction of Env-chimeric FFV genome
pFeFV-7/951
As virions derived from pFeFV-7 were neutralized by
FUV-serotype-specific cat sera (see below), we decided
to construct recombinant FFV genomes that will not be
neutralized by a preexisting immunity against FFV strain
FUV. To this end, the majority of the env gene together
with bel 1 were substituted by corresponding sequences
from the distinct serotype 951 (Flower et al., 1985). By this
rocedure, we wanted to confirm that the known diver-
ent sequences in FFV Env proteins were responsible for
he strain-specific serum neutralization (Winkler et al.,
998). Primers corresponding to the 951-like FFV isolate
17 (Helps and Harbor, 1997) located at nt positions 6418
nd 9901 were used to amplify FFV DNA sequences from
RFK cells infected with FFV isolate 951. The resulting
CR fragment was digested with KpnI and inserted into
he corresponding sites of plasmid pFeFV-7. DNA clone
FeFV-7/951 was genetically stable and directed the syn-
hesis of infectious FFV particles, however, the titer was
nly ;5 3 103 FFU/ml 3 days after transfection when
ompared to the parental clone pFeFV-7. Sequencing of
he chimeric provirus across the exchanged sequence
onfirmed its hybrid structure. Significant sequence dif-
erences between the published FFV Env and Bel 1
rotein sequences and clone pFeFV-7/951 were appar-
nt and are shown in Figs. 1 and 2, respectively. As
xpected, the Env sequence of pFeFV-7/951 strongly
orresponded to the FFV isolate F17 (Helps and Harbor,
997), which was recently shown to represent an 951-like
FV strain (Winkler et al., 1998). The homology of the Bel
transactivator sequence is quite remarkable (Fig. 2). It
s possible that the lower infectivity of clone pFeFV-7/951
an be partially attributed to sequence differences in the
ctivation domain of Bel 1 (He et al., 1993) although the
evels of b-gal expression in infected FFV-FAB cells was
ndistinguishable when compared to the parental clone
FeFV-7 (data not shown).
nalysis of FFV protein expression directed from
ecombinant genomes
The pattern of FFV-protein expression directed from
ecombinant genomes pFeFV-7 and pFeFV-7/951 was
ompared to that of FFV-FUV-infected CRFK cells. With
































































152 ZEMBA ET AL.ains of the amino-terminal part of FFV Gag (Fig. 3A
ag-N), the Pol PR domain (Fig. 3B, PR), the SU do-
ain of FFV Env (Fig. 3C), and the FFV Bel 2/Bet
roteins (Fig. 3D), significant differences were not
etectable in gene expression when wild-type FFV-
nfected cells (Fig. 3, lanes 2) were compared with
ells transfected with recombinant plasmids pFeFV-7
lanes 3) and pFeFV-7/951 (lanes 4). In FFV-infected
nd pFeFV-7- and pFeFV-7/951-transfected cells, the
era specifically detected the full-length and termi-
ally processed Gag proteins (arrowheads in A), the
nprocessed Pro-Pol precursor and the PR-RT-RNase
Pol proteins (long and short arrows in B), the Env
recursor (diamond in C), and the 43-kDa Bet protein
solid arrow in D). Thus FFV gene expression from
ecombinant plasmid pFeFV-7 and pFeFV-7/951 is in-
istinguishable from uncloned, cell-culture-derived
FV virus stocks. The FFV SU antiserum directed
gainst FFV-FUV SU clearly recognized the 951-like
nv protein of clone pFeFV-7/951 as expected because
he amino-terminal part of the recombinant antigen
sed for immunization is highly conserved between
oth serotypes (see Fig. 1). In general, gene expres-
ion of cloned and uncloned FFV strongly resembles
he gene expression profile and degree of proteolytic
rocessing of Gag, Pol, and Env proteins when com-
ared with the prototypic HFV.
eutralization characteristics of recombinant FFV
irions
To investigate the neutralization behavior of the FFV
ecombinants, ;200 FFU as determined on FFV-FAB
ells of virus stocks obtained after transfection with plas-
ids pFeFV-7 and pFeFV-7/951 were incubated with sera
rom naturally FFV-infected Cats 10 or 12 (FUV-like) or
ats 11 or 14 (951-like),and serum from an FFV-negative
at as control (Winkler et al., 1998). Neutralization assays
ere performed as previously described (Winkler et al.,
998) and quantitated on FFV-FAB cells. Sera and dilu-
ions thereof were considered as neutralizing when the
iven initial virus titer was reduced by $75%. Data from
representative serum neutralization experiment per-
ormed in duplicate are summarized in Table 1. It is
vident that serum from FFV-FUV-infected Cat 12 neutral-
zed progeny virus from clone pFeFV-7 but not that de-
ived from plasmid pFeFV-7/951, whereas serum from Cat
4, which had been infected with an 951-like FFV isolate
Winkler et al., 1998), neutralized virus derived form plas-
id pFeFV-7/951 but not that from pFeFV-7 (Table 1). The
FV-negative control serum did not show any neutraliza-
ion activity toward any of the recombinant viruses
ested. We conclude that epitopes relevant for serum
eutralization of FFV are primarily if not exclusively lo-FIG. 1. Sequence analysis of pFeFV-7/951-encoded Env proteins.
omparison of deduced Env sequences of the prototype FFV FUV
equence (top; Winkler et al., 1997), the FFV 951-like isolate F17 (mid-
le; Helps and Harbor, 1997), and chimeric clone pFeFV-7/951 (bottom
ine). The FFV-FUV prototype Env sequence is shown in the single-letter
mino acid code; only divergent residues are given for the other
equences; dots represent gaps in the sequences. The position of the
redicted cleavage site between the SU and TM domain is given by a
ertical arrow, the site corresponding to the 59 end of the exchanged
equences in clone pFeFV-7/951 is marked by an asterisk, and FFV-











153NEUTRALIZATION-RESISTANT FOAMY VIRUS GENOMESDISCUSSION
Here we describe the construction of FFV genomes
hat direct the expression of infectious FFV particles. The
ecombinant FFV genomes are genetically stable and
irect the expression of FFV particles that can be con-
FIG. 3. Comparison of gene expression of uncloned and cloned FFV.
(lanes 4) upon transfection into CRFK cells compared to antigen der
harvested 4 days after transfection or FFV infection and mock infection
sera used were done described previously (Bodem et al., 1998a).
aminoterminal part of FFV Gag (A; Gag-N), the PR domain of Pol (B; P
above the blots detected the full-length and terminally processed
FIG. 2. Sequence analysis of pFeFV-7/951-encoded Bel 1 (Tas) prote
FV-FUV sequence (top; Winkler et al., 1997), the FFV-951-like isolate
bottom line). Asterisks below the aligned sequences mark identical rePR-RT-RNase H proteins (long and short arrows in B), the Env precursor (diam
molecular masses of prestained protein markers separated in parallel are shinuously propagated in cultured cells. The parental wt
rovirus is based on the FFV serotype FUV and its se-
uence almost completely corresponds to that published
reviously (Flower et al., 1985; Winkler et al., 1997). A
erivative of FFV-FUV-based plasmid pFeFV-7, desig-
expression of recombinant clones pFeFV-7 (lanes 3) and pFeFV-7/951
m FFV-infected CRFK cells (lanes 2). Cell-associated antigens were
1). The preparation of cell-associated antigen, immunoblotting, and the
ecific antigens were detected using antisera directed against the
of FFV Env SU (C), and Bel 2/Bet proteins (D.). The sera as specified
oteins (arrowheads in A), the unprocessed Pol precursor and the
mparison of deduced Bel 1 transactivator sequences of the prototype
iddle; Helps and Harbor, 1997), and the chimeric clone pFeFV-7/951
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154 ZEMBA ET AL.nated pFeFV-7/951, contains env and bel 1 sequences
from the distinct FFV serotype 951 (Winkler et al., 1998)
and codes for FFV particles with different neutralization
characteristics as anticipated. The genetic differences
between plasmids pFeFV-7 and pFeFV-7/951 are primar-
ily confined to the central and carboxyl-terminal part of
Env SU as expected from previous studies (Helps and
Harbor, 1997; Winkler et al., 1997, 1998; Wang and Mul-
ligan, 1999) although the activation domain of FFV Bel 1
also shows a significant degree of sequence heteroge-
neity. By means of monospecific antisera directed
against defined structural and nonstructural FFV-FUV
proteins including FUV Env SU, these clones are indis-
tinguishable from each other and from uncloned FFV.
Infectivity derived from both recombinant genomes can
be efficiently quantitated using CRFK cell-derived indica-
tor cells. Importantly, FFV-FAB cells are suited for titration
of FFV derived directly from naturally and experimentally
FFV-infected cats (data not shown), confirming that a
sensitive detection system for cell-culture-derived and
field virus of both FFV serotypes has been established.
However, as expected from our previous study, progeny
virus derived from either FFV proviral genome can be
clearly discriminated by means of strain-specific neutral-
ization and PCR assays.
Our results show that the epitopes that elicited neu-
tralizing antibodies against FFV are confined to the Env
protein, most likely to the distinct central and carboxyl-
terminal part of FFV SU that shows a low degree of
sequence conservation between both serotypes. Other
parts of Env that had not been exchanged in our mutant
as well as other structural and nonstructural FFV pro-
teins are not likely to contribute to serum neutralization
because almost no cross-neutralization between the
wild-type and Env chimeric viruses was detectable in
this and a previous study (Winkler et al., 1998).
According to our data, the parental FFV FUV clone
pFeFV-7 and its Env chimeric derivative pFeFV-7/951 for
which cross-neutralization is not observed, represent a
promising pair of vectors for the repeated administration
TABLE 1








pFeFV-7 0b 1:80–1:160 0b
pFeFV-7/951 0b 0b 1:160–1:320
a Neutralization titers were recorded at the cat antiserum dilution that
nhibited the number of blue cells in FFV-FAB cells by at least 75%.
b Reduction of the FFV titer was not detectable.of recombinant FFV-based vectors for targeted gene de-
livery applications in cats. Engineered vectors derivedfrom both FFV clones carrying therapeutic proteins may
be administered consecutively into cats without clear-
ance of the therapeutic second vector due to pre-estab-
lished neutralizing antibodies induced by previous vector
applications.
To our knowledge this is the first report of a pair of
gene therapy vectors based on the same retroviral back-
bone that do not exhibit serum cross-neutralization, pos-
sibly allowing repeated and successful administration of
the therapeutic vectors. Experiments to investigate
whether successful administration of the two FeFV-
based vectors is possible will be performed.
MATERIALS AND METHODS
Virus, cells, and transfection
FFV strains FUV and 951 have been described previ-
ously and were propagated in CRFK cells (Flower et al.,
1985; Winkler et al., 1998). Electroporation of 10 mg plas-
id DNA into CRFK cells was done at 975 mFd and 160
V in 2-mm cuvettes as described (Winkler et al., 1997).
FFV-FAB cells were selected and maintained in CRFK
cell medium supplemented with 0.5 mg/ml G418 (Boehr-
nger Mannheim, Germany).
onstruction of recombinant DNA
To construct infectious, full-length FFV DNA clones,
FV DNA sequences from nt position 5118 to 7431 (Win-
ler et al., 1997) were amplified by long-template PCR
ith primers 59-CCTCATGCTTACGGGAATAATCTG-
CTG-39 (at FFV genome position 5118–5145, Winkler et
l., 1998) and 59-GAATAGCATACCAGAGCCTACAGGG-
TC-39 (FFV position 7404–7432) and DNA from FFV-
nfected CRFK cells as template as described (Winkler et
l., 1997). Amplicons were cloned into plasmid pCRII
Invitrogen, Groningen, The Netherlands) by standard
echniques (Sambrook et al., 1989; Bodem et al., 1996).
Correct clones were digested with NdeI (in the FFV
sequence) and EclI36II (in pCRII). FFV DNA of ;2.3 kb
was inserted into FFV DNA clone 7 (Winkler et al., 1997)
digested with ClaI, blunt-ended by Klenow DNA polymer-
ase, and digested with NdeI. The resulting FFV clones 24
and 28 extended from nt position 17 to 7431. In parallel,
the FFV insert from plasmids 4, 6, and 8 harboring FFV-
DNA sequences from nt position 8636 to the 39 end of the
39-LTR (Winkler et al., 1997) were subcloned into pBlue-
script KS using common flanking restriction enzyme sites
from the polylinkers. In the resulting clones 5, 7, and 15,
the 39 end of the genome is followed by ClaI and ApaI
sites from the PCR primers and the polylinker sites of the







































155NEUTRALIZATION-RESISTANT FOAMY VIRUS GENOMESamplified by long-template PCR and cloned into plasmid
pCRII as described above, resulting in clone V. To obtain
full-length proviral DNA clones, the cloned ApaI (in the
vector) to PmlI fragment of clones 24 and 28, the PmlI to
stI fragment from clone V, and the PstI to ApaI fragment
rom clones 5, 7, and 15 described above were combined
n three-component ligations. Resulting DNA clones con-
ained FFV DNA from nt position 17 to 11,700 in the
Bluescript backbone. The FFV insert between the flank-
ng EagI and ClaI sites was subcloned into the corre-
pondingly digested vector pAT153 (Sambrook et al.,
989). Finally, FFV DNA sequences from nt 5775 to 10,522
ere amplified by long-template PCR using DNA from
FV-infected CRFK cells and primers 59-TTTGCTC-
GTGGGCAAAGGAAAGGAATATACAATTGG-39 and 59-
TTGACACTGATTTATATGGCACAATAATTCCTCTC-39.
he DNA was directly digested with BstZ17I (nt position
980) and BsaI (nt position 10,137). The FFV DNA frag-
ent of ;4.2 kb was used to substitute for the corre-
ponding sequences of FFV clone 13. FFV clone pFeFV-7
urned out to be genetically stable in bacteria.
An FFV reporter plasmid containing part of the FFV
3 region upstream of a b-galactosidase (b-gal) gene
ontaining a nuclear localization signal was con-
tructed by excising the HFV promoter from plasmid
HSRV5LG (Yu and Linial, 1993) by SmaI and PstI
igestion. FFV-LTR sequences from FFV nt position 33
o 1095 in the U3R region were amplified by PCR using
rimers 59-TCCCCCGGGAATACTCTCTGCTGCC-39 (nu-
leotide position 5118–5145 of FFV genome, Winkler et
l., 1997) and 59-AAACTGCAGCCAAGTCTGTGAGAA-39
FFV position 7404–7432) and cloned FFV DNA as
emplate. The amplicon was digested with SmaI and
stI and inserted into the correspondingly cleaved
ector backbone of plasmid pHSRV5LG (Yu and Linial,
993).
irus neutralization assays
Sera used for neutralization assays have been de-
cribed (Winkler et al., 1998). The titer of FFV derived
rom cleared supernatants of transfected CRFK cells
as determined and infectivity was diluted to a final
iter of ;200 FFU/ml in complete cell culture medium.
Serially diluted cat antisera were added, incubated for
1 h at 37°C under gentle shaking, and added onto
FFV-FAB cells grown in 24-well plates (Winkler et al.,
1998). After 2 h of absorption, the virus was removed
and new medium was added. The remaining infectivity
was determined 2 days later as described above for
FFV-FAB cells. Neutralization was scored positive
when the given titer was reduced by $75% and ex-
pressed as the highest serum dilution that still re-
sulted in FFV neutralization.Preparation of monospecific antisera and
immunoblotting
Defined domains of FFV gag and env genes were
amplified by PCR using pFeFV-7 DNA as template, sub-
cloned into pCRII plasmids, excised with restriction en-
zymes whose recognition sites had been introduced into
the primers, and cloned between the NdeI to BamHI
sites of prokaryotic expression plasmids pET16b. To ex-
press FFV Gag residues 1–210, primers 59-TCATATG-
GCTCGAGAATTAAATCCTC-39 and 59-AGGATCCTA-
AAATACTCCTTCAATAGCGGC-39 were used; the ampli-
con was excised using NdeI and BamHI. To express
residues 101–402 of Env SU, primers 59-CATATGGGC-
CCAGTCTTAAGCTGG-39 and 59-AGATCTCCTTCCCAT-
AGTGAG-39 were used; FFV sequences were excised
with NdeI and BglII. The FFV protease (PR; Pol residues
1–140) was PCR-amplified using primers 59-GGGGGTAC-
CGACGACGACGACAAGATGGATCTGCTGAAGCCG-39
and 59-CGCGGATCCTTAATTCTCCCAACTTTGCCATAA-
39; excised with KpnI and BamHI and inserted into the
correspondingly cleaved pET32a vector. Expression and
purification of recombinant proteins were done as de-
scribed previously (Bodem et al., 1998a). The immuniza-
tion of rabbits was performed by Eurogentec, Seraing,
Belgium. The FFV Bel 2/Bet antiserum and immunoblot-
ting have been described recently (Bodem et al., 1998a).
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